Euclidean Capital LLC

10% Owner
Euclidean Capital LLC
$84,608,000.00
%
COMPANY
SHARES
NET TOTAL
39.36%
PMV PHARMACEUTICALS INC
2,336,909
$33,301,000.00
20.27%
FOGHORN THERAPEUTICS INC
1,261,261
$17,153,000.00
11.78%
ALECTOR INC
980,894
$9,966,000.00
11.31%
NGM BIOPHARMACEUTICALS INC
746,674
$9,572,000.00
9.34%
RAPT THERAPEUTICS INC
432,900
$7,900,000.00
3.98%
FIRST FINL BANCORP OH
173,576
$3,367,000.00
3.96%
ORIC PHARMACEUTICALS INC
747,550
$3,349,000.00